Cafepharma Today

June 5 2025 - GLP-1 drugs may be linked to elevated risk of serious eye disease, study finds
GLP-1 drugs may be linked to elevated risk of serious eye disease, study finds
Bispecific cancer drugs, data caveats and funding alarms: 3 takeaways from ASCO
FDA’s Elsa AI is here, and the industry has questions
Merck gains U.S. patent office support in Keytruda dispute
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

Biogen shares up 5% on BIIB037 results, Alzheimer's drug showed effect on cognition
CNBC
Tuesday, December 2, 2014 - 8:46am
tags:
Biogen Idec, BIIB037, Alzheimer's disease
The Debate Over The Cost To Develop A New Drug
Forbes
Tuesday, December 2, 2014 - 8:45am
tags:
R&D, development costs
Meet 5 Top Drug Stocks That Are Bolting Past Market
Investors.com
Tuesday, December 2, 2014 - 8:42am
tags:
Celgene, Amgen, AstraZeneca, Hospira, Amag Pharmaceuticals
Japan’s Otsuka to buy U.S. drug maker Avanir for $3.5 billion
Fortune
Tuesday, December 2, 2014 - 8:39am
tags:
Otsuka, M&A, Avanir
No serious side effects in Merck/Newlink Ebola vaccine test
Yahoo/Reuters
Tuesday, December 2, 2014 - 8:05am
tags:
Merck, NewLink Genetics, vaccines, ebola virus
FDA lifts hold on Flexion's lead drug
Yahoo/Reuters
Monday, December 1, 2014 - 7:33pm
tags:
FDA, Flexion, FX006, osteoarthritis
After Initial Testing, Italian Regulator Now Says Novartis Flu Vaccine is Safe
WSJ Pharmalot
Monday, December 1, 2014 - 7:32pm
tags:
Novartis, vaccines, flu vaccine, Italy, Fluad
Celgene Hits 52-Week High on Positive CHMP Opinion
Yahoo/Zacks.com
Monday, December 1, 2014 - 7:31pm
tags:
Celgene, CHMP, Europe, Otezla
5 Critical Biotech Drug Dates and Events for December
24/7 Wall St
Monday, December 1, 2014 - 4:45pm
tags:
biotech, Incyte, ruxolitinib, Cubist Pharma, ceftolozane/tazobactam, Biocryst, peramivir, Vertex Pharmaceuticals, Kalydeco, Pozen, PA8140/PA32540
Pfizer closes $635M vaccines purchase from Baxter
Yahoo/AP
Monday, December 1, 2014 - 4:42pm
tags:
Pfizer, vaccines, M&A, Baxter International
Exelixis drops 15% after prostate cancer drug candidate fails Phase 3
Seeking Alpha
Monday, December 1, 2014 - 11:31am
tags:
Exelixis, prostate cancer, cabozantinib
Want to relocate to Asia? What pharma recruiters really look for
In-Pharma Technologist
Monday, December 1, 2014 - 11:28am
tags:
Asia, jobs, pharma recruiters
Bristol-Myers Cuts Jobs in China as Drug Makers Rethink Marketing
WSJ Pharmalot
Monday, December 1, 2014 - 11:22am
tags:
Bristol-Myers Squibb, China, layoffs
J&J bets up to $277M on a prospect from its R&D farm system
Fierce Biotech
Monday, December 1, 2014 - 11:19am
tags:
JNJ, R&D, Modern Biosciences
FDA to Review Eylea for Diabetic Retinopathy
Monthly Prescribing Reference
Monday, December 1, 2014 - 10:36am
tags:
FDA, Eylea, diabetic retinopathy, Regeneron
Should The FDA Force Drug Makers To Discuss Their Clinical Trials?
Forbes
Monday, December 1, 2014 - 10:17am
tags:
FDA, clinical trials
Using Doctors With Troubled Pasts to Market a Painkiller
NY Times, NY
Monday, December 1, 2014 - 10:13am
tags:
physicians, painkillers, INSYS Therapeutics
Novartis’s Gilenya Fails to Help Hard-to-Treat Form of MS
Bloomberg
Monday, December 1, 2014 - 9:59am
tags:
Novartis, Gilenya, MS, multiple sclerosis
Mylan to Manufacture, Distribute Gilead Sciences HIV Drug
Marketwatch
Monday, December 1, 2014 - 9:58am
tags:
Mylan Labs, HIV, Gilead Sciences, tenofovir
Northwest Biotherapeutics: An Analysis Of What We Know About DCVax Direct
Seeking Alpha
Monday, December 1, 2014 - 9:17am
tags:
DCVax Direct, Northwest Biotherapeutics, cancer, immuno-oncology

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

Not One of Your Easy Crystals
In the Pipeline
The Continuing Crisis, Part XV: The Horrendous Trump Budget
In the Pipeline
Taurine Revisited
In the Pipeline
A New Route to Asthma Treatment - Through the Liver, of All Places
In the Pipeline
One Drug's Supply Chain, In Detail
In the Pipeline
A Reaction to Alzheimer's Fraud
In the Pipeline
Whoa Now: Cautionary Tales from Materials Science
In the Pipeline
Inside a Scientific Paper Mill
In the Pipeline
Autoimmune Disease, Transformed?
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.